Biosimilars for the Treatment of Psoriasis-A Systematic Review of Clinical Trials and Observational Studies: Looking Beyond Single-Trial Evidence for a Valuable Choice

JAMA Dermatol. 2023 Jul 1;159(7):697-699. doi: 10.1001/jamadermatol.2023.1331.

Authors

Luigi Naldi^{1

2}, Antonio Addis³

Affiliations

¹ Centro Studi GISED, Bergamo, Italy.
² Department of Dermatology, AULSS8, Ospedale San Bortolo, Vicenza, Italy.
³ Unit of Drug Epidemiology, Department of Epidemiology, Regione Lazio, Rome, Italy.

PMID: 37256632
DOI: 10.1001/jamadermatol.2023.1331

No abstract available

Publication types

Editorial
Systematic Review
Comment

MeSH terms

Biosimilar Pharmaceuticals* / therapeutic use
Clinical Trials as Topic
Humans
Observational Studies as Topic
Psoriasis* / drug therapy

Substances

Biosimilar Pharmaceuticals